Compare FKWL & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FKWL | ABVC |
|---|---|---|
| Founded | 1981 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 26.1M |
| IPO Year | 1997 | 2009 |
| Metric | FKWL | ABVC |
|---|---|---|
| Price | $2.25 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.3K | ★ 90.5K |
| Earning Date | 11-13-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,514,405.00 | $509,589.00 |
| Revenue This Year | $32.55 | N/A |
| Revenue Next Year | N/A | $171.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.17 | $0.71 |
| 52 Week High | $5.48 | $3.06 |
| Indicator | FKWL | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 40.45 | 40.06 |
| Support Level | $2.23 | $0.71 |
| Resistance Level | $2.50 | $1.14 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 26.80 | 5.63 |
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics. Geographically, it derives revenue from North America, which derives maximum revenue; and Asia.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.